Growth Metrics

CervoMed (CRVO) Operating Margin (2023 - 2025)

Historic Operating Margin for CervoMed (CRVO) over the last 9 years, with Q3 2025 value amounting to 2493.79%.

  • CervoMed's Operating Margin fell 22156000.0% to 2493.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 441.64%, marking a year-over-year decrease of 3078600.0%. This contributed to the annual value of 187.18% for FY2024, which is 778300.0% down from last year.
  • CervoMed's Operating Margin amounted to 2493.79% in Q3 2025, which was down 22156000.0% from 376.41% recorded in Q2 2025.
  • CervoMed's Operating Margin's 5-year high stood at 71.57% during Q2 2023, with a 5-year trough of 2493.79% in Q3 2025.
  • Moreover, its 3-year median value for Operating Margin was 175.25% (2023), whereas its average is 400.84%.
  • Its Operating Margin has fluctuated over the past 5 years, first plummeted by -92400bps in 2024, then tumbled by -22156000bps in 2025.
  • Over the past 3 years, CervoMed's Operating Margin (Quarter) stood at 99.59% in 2023, then plummeted by -236bps to 334.91% in 2024, then tumbled by -645bps to 2493.79% in 2025.
  • Its Operating Margin was 2493.79% in Q3 2025, compared to 376.41% in Q2 2025 and 276.55% in Q1 2025.